Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer
about
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients.Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars.Biosimilar insulins are coming: the top 10 things you should know.Is there a reason for concern or is it just hype? - A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars.Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countries.Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience.Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function.Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.The role of biosimilars in value-based oncology care
P2860
Q26863707-F44FABEF-5B8F-4AB7-9153-8BB10AFBBC81Q34485713-1825B6ED-937D-47DA-B2F4-82CC04C69029Q36387871-FE7669DA-C0D7-4AEE-A800-8247FA39B462Q37028832-CBB986E4-DDD9-49D7-8DB4-80FFF147B7BDQ37263146-5E2BDBCA-A81C-465B-9229-6795002952A0Q37391931-656AB31C-5365-473B-8262-5932DF907FEEQ37474361-BD2A474E-FF75-4088-BD88-35244629365EQ38219486-5131E1AD-798C-4656-AC08-98D3E7791325Q38708927-2360787E-78FB-46F7-ADF6-12FDA6630CA1Q39141802-3EF5E8C1-2852-489D-A2DC-94DE8C1BAABEQ39293869-DFD2129B-6659-4C9E-8CC4-E337D1B7E688Q47572205-AB5DAB87-AC45-4067-882B-3590209D4D03Q47760510-D14CA655-F880-472A-BDF0-7BB780EBDD56Q48080576-747F8214-75D4-4F00-BC27-A5A3E79572AEQ48088431-0B5A5E1C-6802-4B3F-9E7D-74F9914B6957Q51197806-BDC76AFB-5151-4DBA-9877-7FCC73BDF914Q58605622-58E1FFB1-93E8-4BD0-B0CC-72D0BF85B84C
P2860
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparative cost efficiency ac ...... anemia in patients with cancer
@ast
Comparative cost efficiency ac ...... anemia in patients with cancer
@en
type
label
Comparative cost efficiency ac ...... anemia in patients with cancer
@ast
Comparative cost efficiency ac ...... anemia in patients with cancer
@en
prefLabel
Comparative cost efficiency ac ...... anemia in patients with cancer
@ast
Comparative cost efficiency ac ...... anemia in patients with cancer
@en
P2093
P2860
P356
P1476
Comparative cost efficiency ac ...... anemia in patients with cancer
@en
P2093
Ivo Abraham
Matti Aapro
Paul Cornes
P2860
P304
P356
10.1177/1758834012444499
P577
2012-05-01T00:00:00Z